NCT02715570View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions

Aspergillosis

Interventions

DRUG

PC945 - single doses

Safety and tolerability of single doses

DRUG

Placebo - single doses

Safety and tolerability of single doses

DRUG

PC945 - repeat doses

Safety and tolerability of repeat doses

DRUG

Placebo - repeat doses

Safety and tolerability of repeat doses

Trial Locations (1)

HA1 3UJ

Parexel EPCU, Harrow

All Listed Sponsors

lead

Pulmocide Ltd

INDUSTRY

NCT02715570 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945 | Biotech Hunter | Biotech Hunter